|
David A. Fraulino, DOAssistant Professor of Medicine
|
|
||||||||||
Dr. Fraulino completed his medical degree from the University of New England in 2017. He then completed Internal Medicine residency at the University of Connecticut in 2020 and Infectious Disease fellowship at the University of Colorado. While in Colorado, he underwent specialty training at National Jewish Hospital in treating mycobacterial lung infections. He is board-certified in both Internal Medicine and Infectious Disease.
| Degree | Institution | Major |
|---|---|---|
| BS | Salve Regina University | Biology and Chemistry |
| DO | University of New England College of Osteopathic Medicine | Medicine |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Fellowship | National Jewish Hospital | Infectious Disease Rotating Mycobacteriology Fellowship |
| Residency | UConn School of Medicine | Internal Medicine |
| Fellowship | University of Colorado Anschutz Medical Campus | Infectious Diseases |
Awards
| Name of Award/Honor | Awarding Organization |
|---|---|
| Medical Intern of the Year 2017-2018 | UConn School of Medicine Internal Medicine Residency Program |
| National Poster Award Winner | American College of Osteopathic Internists Annual Meeting |
| Most Outstanding Research Poster | Eastern Connecticut Health Network |
| Most Original Research Project | Eastern Connecticut Health Network |
| Who's Who Among Students in America's Universities and Colleges | Salve Regina University |
| Regional Award for Best Platform Presentation | 5th Annual BioNES Meeting |
| Dorothy Perkins Sisson '51 Memorial Scholarship | Salve Regina University |
| National College Athlete Honor Society | Chi Alpha Sigma |
| Scholar All-Region Team (2008-2010) | National Soccer Coach's Association of America |
Nontuberculous mycobacterial lung infections, HIV, Hepatitis C/B, and STIs
Dr. Fraulino teaches medical students, intern/resident/fellow physicians, and lectures nationally/internationally on his areas of research.
Dr. Fraulino conducts clinical research in the areas of nontuberculous mycobacterial lung infections and bronchiectasis.
Journal Articles
-
The Association Between Incident Nontuberculous Mycobacteria Isolation and Antibiotic Exposure in Patients with Bronchiectasis.
Chest 2025 Oct;
-
Mycobacterium nebraskense Isolated from Patients in Connecticut and Oregon, USA.
Emerging infectious diseases 2025 Mar;31(3):507-515
-
Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
American journal of respiratory and critical care medicine 2024 Apr;
-
Latent tuberculosis infection in the outpatient general medicine clinic: Efficacy of a nurse-run electronic directly observed treatment program.
Preventive medicine reports 2023 Oct;35102321
-
Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis.
Frontiers in pharmacology 2022 Jan;13910516
-
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
Nature genetics 2016 Jan;48(1):74-8
-
A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome.
The Journal of allergy and clinical immunology 2012 Dec;130(6):1414-6
Case Reports
Reviews
-
Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review.
Postgraduate medicine 2024 Sep;136(7):770-781